Screener
ANI Pharmaceuticals ANIP Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: ANI Pharmaceuticals’s 10-K, filed February 27, 2026.
- Filed
- Feb 27, 2026, 6:59 AM EST
- Fiscal year
- FY2025
- Accession
- 0001023024-26-000014
| (in thousands) | ||
|---|---|---|
| 2026 | $ | $150 |
| 2027 | 8 | |
| Total minimum lease payments | $ | $158 |
| Less: effects of discounting | (6) | |
| Present value of future minimum lease payments | 152 | |
| Less: current lease liability, included in accrued expenses and other | (104) | |
| Non-current lease liability, included in other non-current liabilities | $ | $48 |
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is ANI Pharmaceuticals's finance lease liabilities?
- ANI Pharmaceuticals (ANIP) reported finance lease liabilities of $48K in Q4 2025.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about ANI Pharmaceuticals's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude